HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isidre Ferrer Selected Research

N(epsilon)-(malondialdehyde)lysine

6/2005Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isidre Ferrer Research Topics

Disease

74Alzheimer Disease (Alzheimer's Disease)
06/2022 - 10/2003
41Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 05/2002
35Parkinson Disease (Parkinson's Disease)
09/2020 - 05/2002
18Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2022 - 12/2004
16Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2022 - 10/2008
14Disease Progression
01/2021 - 12/2006
14Amyloid Plaque
01/2021 - 10/2003
14Dementia (Dementias)
01/2021 - 09/2005
11Sporadic Creutzfeldt-Jakob Disease
06/2022 - 01/2014
10Cognitive Dysfunction
01/2021 - 02/2008
10Schizophrenia (Dementia Praecox)
01/2020 - 07/2013
9Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2020 - 12/2004
9Pick Disease of the Brain (Pick's Disease)
02/2016 - 03/2004
7Tauopathies
01/2022 - 08/2005
7Inflammation (Inflammations)
01/2022 - 03/2010
7Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
02/2016 - 12/2008
7Huntington Disease (Huntington's Disease)
09/2013 - 11/2008
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 04/2008
6Neuroblastoma
11/2010 - 05/2002
6Myofibrillar Myopathy
03/2009 - 06/2007
5Neuroinflammatory Diseases
01/2020 - 01/2014
4Gliosis
01/2018 - 12/2008
4Scrapie
01/2017 - 10/2008
4Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
02/2016 - 03/2010
4Mitochondrial Diseases (Mitochondrial Disease)
02/2014 - 12/2007
4Parkinsonian Disorders (Parkinsonism)
05/2011 - 05/2002
4Synucleinopathies
03/2010 - 05/2006
3Multiple Sclerosis
01/2022 - 12/2004
3Seizures (Absence Seizure)
06/2020 - 02/2003
3Lewy Body Disease (Lewy Body Dementia)
01/2018 - 09/2005
3Demyelinating Diseases (Demyelinating Disease)
01/2017 - 12/2004
3Neoplasms (Cancer)
01/2015 - 02/2003
3Bovine Spongiform Encephalopathy (Mad Cow Disease)
11/2009 - 10/2007
3Motor Neuron Disease (Primary Lateral Sclerosis)
08/2009 - 12/2008
3Muscular Diseases (Myopathy)
03/2009 - 06/2007
2Starvation
01/2022 - 02/2014
2Fatal Familial Insomnia
01/2021 - 01/2018
2Acquired CJD
12/2020 - 08/2015
2Infections
12/2020 - 02/2014
2Frontotemporal Dementia (Semantic Dementia)
09/2020 - 06/2014
2Lafora Disease
06/2020 - 01/2017
2Psychotic Disorders (Schizoaffective Disorder)
11/2016 - 11/2014

Drug/Important Bio-Agent (IBA)

54Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2002
23Amyloid (Amyloid Fibrils)IBA
01/2022 - 10/2003
18LipidsIBA
01/2022 - 06/2005
17Prion ProteinsIBA
01/2021 - 10/2008
14Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 12/2004
13Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2014
10Messenger RNA (mRNA)IBA
01/2020 - 07/2013
9Protein AggregatesIBA
01/2017 - 10/2007
8alpha-SynucleinIBA
01/2019 - 05/2002
8Phosphotransferases (Kinase)IBA
05/2018 - 03/2004
7PrionsIBA
06/2022 - 02/2014
7EnzymesIBA
01/2022 - 03/2009
7Peptides (Polypeptides)IBA
01/2021 - 01/2004
7UbiquitinIBA
01/2018 - 10/2007
7AntioxidantsIBA
11/2015 - 09/2008
6CytokinesIBA
01/2019 - 01/2014
6MicroRNAs (MicroRNA)IBA
01/2018 - 03/2009
5SynucleinsIBA
09/2020 - 08/2010
5RNA (Ribonucleic Acid)IBA
01/2020 - 07/2013
5Docosahexaenoic AcidsIBA
01/2020 - 06/2005
5Adenosine (Adenocard)FDA LinkGeneric
08/2019 - 03/2010
5Protein Isoforms (Isoforms)IBA
05/2018 - 08/2005
4Pharmaceutical PreparationsIBA
01/2020 - 08/2013
4CannabinoidsIBA
11/2018 - 05/2011
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2018 - 04/2010
4Presenilin-1IBA
02/2016 - 12/2006
4Amyloid beta-PeptidesIBA
10/2009 - 01/2004
3Member 1 Subfamily D ATP Binding Cassette TransporterIBA
01/2022 - 12/2012
3Biological ProductsIBA
01/2021 - 06/2005
3Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 11/2014
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
08/2019 - 04/2014
3sarkosylIBA
04/2015 - 05/2006
3Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2015 - 10/2003
3Levodopa (L Dopa)FDA LinkGeneric
04/2010 - 07/2002
2Peptide Hydrolases (Proteases)FDA Link
06/2022 - 03/2010
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022 - 01/2016
2EndocannabinoidsIBA
01/2022 - 01/2014
2Codon (Codons)IBA
01/2021 - 11/2016
2CannabidiolIBA
06/2020 - 08/2019
2ProteomeIBA
01/2020 - 01/2019
2CalciumIBA
01/2020 - 01/2017
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020 - 01/2010
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
08/2019 - 11/2018
2NeuroserpinIBA
12/2017 - 02/2016
2CalpainIBA
01/2017 - 01/2008
2PresenilinsIBA
01/2017 - 02/2013
2AlbuminsIBA
01/2017 - 07/2009
2GlycogenIBA
11/2016 - 02/2014
2Mitochondrial DNA (mtDNA)IBA
02/2016 - 02/2014
25-Methylcytosine (5 Methylcytosine)IBA
02/2016 - 06/2013
2purineIBA
12/2015 - 01/2015
2DNA (Deoxyribonucleic Acid)IBA
12/2015 - 08/2009
2Pioglitazone (Actos)FDA Link
11/2015 - 08/2013
2ResveratrolIBA
11/2015 - 01/2014
2Sirolimus (Rapamycin)FDA Link
11/2015 - 09/2013
2Leucine (L-Leucine)FDA Link
01/2015 - 03/2009

Therapy/Procedure

12Therapeutics
01/2022 - 06/2008
2Plasma Exchange
01/2017 - 07/2009